GLP-1 medications such as Ozempic, Wegovy and Mounjaro are increasingly used for weight loss and diabetes management, but many patients planning IVF, egg freezing or pregnancy wonder whether they are safe during fertility treatment. In this article, Dr Julija Gorodeckaja explains how these medications work, why they need to be stopped before IVF or egg freezing, and the current guidance for people trying to conceive.
In recent months, many fertility patients have been asking an important and increasingly common question:
These medications are becoming more widely used, both for diabetes management and for weight loss, and it’s completely understandable that patients planning pregnancy, IVF, IUI or egg freezing want clear information.
This article explains what GLP-1 medications are, how they work, and what’s currently advised for people undergoing fertility treatment.
GLP-1 medications are prescription drugs that help regulate appetite and blood sugar. GLP-1 stands for glucagon-like peptide 1, a natural hormone produced in the gut that plays a role in:
These medications have become well known for their effects on weight loss, but they were originally developed for type 2 diabetes.
Some of the most frequently prescribed GLP-1 medications include:
At The Evewell, we often see patients using these medications before starting IVF or egg freezing, particularly where weight management or metabolic health is part of their journey.
GLP-1 medications support weight loss and metabolic health by:
That last point is especially important in fertility treatment, because delayed gastric emptying can affect sedation safety during procedures such as egg collection.
This is a very common question, especially for patients with PCOS or insulin resistance. Some people may notice improved ovulation or cycle regularity after weight loss or improved metabolic control.
However, GLP-1 medications aren’t fertility drugs, and they aren’t prescribed as a direct fertility treatment. Their role is usually part of a broader health picture.
If you’re considering GLP-1s for fertility reasons, it’s essential to discuss this with both your GP and fertility specialist.
The current guidance is that GLP-1 medications should be stopped before pregnancy and before key stages of fertility treatment, because the effects on pregnancy aren’t fully known. This includes treatment such as:
Egg collection is typically performed under sedation. GLP-1 medications slow stomach emptying, increasing the risk of reflux or regurgitation during sedation, which can compromise the airway.
For this reason, The Evewell guidance advises that patients should stop GLP-1 medications at least 4 weeks before sedation procedures, including egg collection.
The MHRA and current clinical guidance recommend specific washout periods for each medication.
This is relevant if you plan to have an embryo transfer or insemination, and you should always discuss timing with your consultant.
This article is for general information only and isn’t medical advice. GLP-1 medications are prescription drugs that must always be taken under appropriate medical supervision. If you’re currently taking a GLP-1 medication, or considering one, and you’re:
You must speak to your GP, prescribing clinician, and fertility specialist before making any changes. You shouldn’t stop or start prescription medication without medical guidance.
Fertility treatment can be stressful and anxiety-provoking, and questions around medication are very common.
At The Evewell, all patients are offered access to supportive counselling and guidance throughout their treatment journey. If you’re unsure about GLP-1 medications and your treatment timeline, please speak to your consultant team.